Literature DB >> 24773698

Duration between onset and diagnosis in central nervous system tumors: impact on prognosis and functional outcome.

Kohei Fukuoka1, Takaaki Yanagisawa1, Tomonari Suzuki1, Mitsuaki Shirahata2, Jun-Ichi Adachi2, Kazuhiko Mishima2, Takamitsu Fujimaki3, Masao Matsutani2, Ryo Nishikawa2.   

Abstract

BACKGROUND: The initial presentation of central nervous system (CNS) tumors in children frequently mimics other more common and less serious conditions, resulting in diagnostic difficulty and a prolonged time to diagnosis. Yet whether early diagnosis contributes to better life prognosis and functional outcome has not been elucidated. Only a few such reports have originated from Japan, where neuroimaging techniques are the best in the world. We examined the time to diagnosis, the so-called prediagnostic symptomatic interval (PSI), and its impact on prognosis and functional outcome in children with CNS tumors.
METHODS: We reviewed the records of 127 patients aged <15 years with CNS tumors, who were treated at our two institutions between November 1993 and October 2011.
RESULTS: The median age at diagnosis was 7.2 years (range, 3 weeks-14.9 years). The male-to-female ratio was 63:64. Median PSI was 1.5 months (0-36 months). Overall survival and progression-free survival did not differ significantly between the groups, regardless of whether the PSI was longer than the median PSI. The PSI was significantly longer in patients with long-lasting clinical signs after the initial treatment than in patients with temporary symptoms only at onset. Both univariate and multivariate analysis showed that high histological grading was statistically correlated with short PSI.
CONCLUSIONS: A short PSI was significantly associated with high-grade tumors. Earlier diagnosis did not lead to better life prognosis, but possibly to better functional outcome in children with CNS tumors.
© 2014 Japan Pediatric Society.

Entities:  

Keywords:  childhood brain tumor; diagnosis; pediatric neuro-oncology; prediagnostic symptomatic interval; prognosis

Mesh:

Year:  2014        PMID: 24773698     DOI: 10.1111/ped.12369

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  7 in total

1.  Diagnostic delay in children with central nervous system tumors and the need to improve education.

Authors:  Ibrahim Qaddoumi; Thomas E Merchant; Fredrick A Boop; Amar Gajjar
Journal:  J Neurooncol       Date:  2019-11-05       Impact factor: 4.130

2.  Patterns, treatments, and outcomes of pediatric central nervous system tumors in Sudan: a single institution experience.

Authors:  M Mohammed Ali Elhassan; A Abdalla Mohamedani; H Hussein Mohammed Osman; N Osman Yousif; N Mohamed Elhaj; I Qaddoumi
Journal:  Childs Nerv Syst       Date:  2019-01-04       Impact factor: 1.475

3.  Childhood Cancer Survival, 2006-2012 Cohorts of Mexican Institute of Social Security Beneficiaries at the Central-South Region of Mexico.

Authors:  Angélica Castro-Ríos; Silvia Martínez-Valverde
Journal:  Front Oncol       Date:  2022-07-01       Impact factor: 5.738

4.  Initial symptoms and diagnostic delay in children with brain tumors at a single institution in Japan.

Authors:  Yuji Yamada; Daiki Kobayashi; Keita Terashima; Chikako Kiyotani; Ryuji Sasaki; Nobuaki Michihata; Toru Kobayashi; Hideki Ogiwara; Kimikazu Matsumoto; Akira Ishiguro
Journal:  Neurooncol Pract       Date:  2020-10-06

5.  The Role of Time as a Prognostic Factor in Pediatric Brain Tumors: a Multivariate Survival Analysis.

Authors:  Eduardo Javier Barragán-Pérez; Carlos Enrique Altamirano-Vergara; Daniel Eduardo Alvarez-Amado; Juan Carlos García-Beristain; Fernando Chico-Ponce-de-León; Vicente González-Carranza; Luis Juárez-Villegas; Chiharu Murata
Journal:  Pathol Oncol Res       Date:  2020-07-13       Impact factor: 2.874

6.  Clinical presentation of young people (10-24 years old) with brain tumors: results from the international MOBI-Kids study.

Authors:  Angela Zumel-Marne; Michael Kundi; Gemma Castaño-Vinyals; Juan Alguacil; Eleni Th Petridou; Marios K Georgakis; Maria Morales-Suárez-Varela; Siegal Sadetzki; Sara Piro; Rajini Nagrani; Graziella Filippini; Hans-Peter Hutter; Rajesh Dikshit; Adelheid Woehrer; Milena Maule; Tobias Weinmann; Daniel Krewski; Andrea T Mannetje; Franco Momoli; Brigitte Lacour; Stefano Mattioli; John J Spinelli; Paul Ritvo; Thomas Remen; Noriko Kojimahara; Amanda Eng; Angela Thurston; Hyungryul Lim; Mina Ha; Naohito Yamaguchi; Charmaine Mohipp; Evdoxia Bouka; Chelsea Eastman; Roel Vermeulen; Hans Kromhout; Elisabeth Cardis
Journal:  J Neurooncol       Date:  2020-03-03       Impact factor: 4.130

7.  Clinical profile, treatment and outcome of pediatric brain tumors in Serbia in a 10-year period: A national referral institution experience.

Authors:  Dragana Stanić; Danica Grujičić; Tatjana Pekmezović; Jelena Bokun; Marija Popović-Vuković; Dragana Janić; Lejla Paripović; Vesna Ilić; Marija Pudrlja Slović; Rosanda Ilić; Savo Raičević; Milan Sarić; Ivana Mišković; Borko Nidžović; Marina Nikitović
Journal:  PLoS One       Date:  2021-10-26       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.